Lymphomatoid granulomatosis - A report on four cases: Evidence for B phenotype of the tumoral cells

European Respiratory Journal

Volumn 12, Issue 1, 1998, Pages 102-106

  Taniere Ph ^a   Thivolet Bejui F ^b   Vitrey, D ^b   Isaac, S ^c   Loire, R ^d   Cordier, J F ^e   Berger, F ^a,f  

^a Laboratoire d'Anatomie Pathologique   (France)

^b CROIX ROUSSE HOSPITAL   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d LOUIS PRADEL HOSPITAL   (France)

^e Service de Pneumologie   (France)

^f EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Angiocentric lymphoma; Angioimmunoproliferative lesion; Epstein Barr nuclear antigen 2; Epstein Barr virus; Latent membrane protein; Lymphatoid granulomatosis

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; MEMBRANE PROTEIN; VIRUS PROTEIN;

ADULT; ARTICLE; CASE REPORT; CELL PROLIFERATION; CHEMOTHERAPY; EPSTEIN BARR VIRUS; FEMALE; HISTIOCYTE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LYMPHOMATOID GRANULOMATOSIS; MALE; MORTALITY; PATHOGENESIS; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CHARACTERIZATION;

ADULT; ANTIGENS, CD; B-LYMPHOCYTES; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; LUNG; LUNG NEOPLASMS; LYMPHOMATOID GRANULOMATOSIS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED;

EID: 2642620216     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12010102     Document Type: Article

References (34)

1. Liebow AA, Carrington CR, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol 1972; 3: 457-548.
2. Jaffe ES. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest 1984; 2: 413-426.
3. Lipford EH, Margolick JB, Longo DL, Fauci LA, Jaffe ES. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 1988; 72: 1674-1681.
4. Bleiweiss IJ, Strauchen JA. Lymphomatoid granulomatosis of the lung: report of a case and gene rearrangement studies. Hum Pathol 1988; 19: 1109-1122.
5. Donner LR, Dobin S, Harrington D, Bassion S, Rappaport ES, Peterson RF. Angiocentric immunoproliferative lesions (Iymphomatoid granulomatosis). A cytogenetic, immunophenotypic, and genotypic study. Cancer 1990; 65: 249-254.
6. Gaulard Ph, Henni T, Marolleau JP, et al. Lethal midline granuloma (polymorphic reticulosis) and Iymphomatoid granulomatosis. Cancer 1988; 62: 705-710.
7. Medeiros LJ, Peiper SC, Elwood L, Yano T, Raffeld M, Jaffe ES. Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. Hum Pathol 1991; 22: 1150-1157.
8. Guinee D, Jaffe E, Kingma D, et at. Pulmonary Iymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol 1994; 18: 753-764.
9. Myers JL, Kurtin PJ, Katzenstein AL, et al. Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection. Am J Surg Pathol 1995; 19: 1300-1312.
10. Wyndham HW, Kingma DW, Raffeld M, Wittes RE, Jaffe ES. Association of Iymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-α2b. Blood 1996; 87: 4531-4537.
11. Nicholson AG, Wotherspoon AC, Diss TC, et al. Lymphomatoid granulomatosis: evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma. Histopathology 1996; 29: 317-324.
12. Ho FCS, Choy D, Loke SL, et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol 1990; 21: 1041-1050.
13. Kanaveros P, De Bruin PC, Briere J, Meijer CJ, Gaulard Ph. Epstein-Barr virus (EBV) in extra-nodal T-cell non-Hodgkin's Iymphomas (T-NHL). Identification of nasal T-NHL as a distinct clinicopathological entity associated with EBV. Leukemia Lymphoma 1995; 18: 27-34.
14. Strickler JG, Meneses MF, Habermann TM, et al. Polymorphic reticulosis: a reappraisal. Hum Pathol 1994; 25: 659-665.
15. Jaffe ES, Chan JK, Frizzera G, Mori S, Feller AC, Ho FC. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell Iymphomas. Am J Surg Pathol 1996; 20: 103-111.
16. Katzenstein AL, Peiper SC. Detection of Epstein-Barr virus genomes in lymphomatoid granulomatosis: analysis of 29 cases by the polymerase chain reaction technique. Mod Pathol 1990; 3: 435-441.
17. Medeiros LJ, Jaffe ES, Chen YY, Weiss LM. Localization of Epstein-Barr viral genomes in angiocentric immuno-proliferative lesions. Am J Surg Pathol 1992; 16: 439-447.
18. Delecluse HJ, Kremmer E, Rouault JP, Cour C, Bornkamm G, Berger F. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. Am J Pathol 1995; 146: 1113-1120.
19. Zimber Strobl U, Kremmer E, Grasser F, Marschall G, Laux G, Bornkamm GW. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J 1993; 12: 167-175.
20. Henderson S, Rowe M, Gregory C, Wang F, Kieff E, Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein-1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107-1115.
21. Rowe M, Peng-Pilon M, Huen DS, et al. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell specific response that is delayed relative to NF-kB activation and to induction of cell surface markers. J Virol 1994; 68: 5602-5612.
22. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985; 43: 831-840.
23. Wang F, Gregory CD, Rowe M, et al. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci USA 1987; 84: 3452-3456.
24. Cordier M, Calender A, Billaud M, et al. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J Virol 1990; 64: 1002-1013.
25. Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG. T cell recognition of Epstein-Barr virus associated lymphomas. Cancer Surv 1992; 13: 53-80.
26. Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 1991; 173: 147-158.
27. Hammar SP, Mennemeyer R. Lymphomatoid granulomatosis in a renal transplant recipient. Hum Pathol 1976; 7: 111-116.
28. Troussard X, Galateau F, Gaulard Ph, et al. Lymphomatoid granulomatosis in a patient with acute myeloblastic leukemia in remission. Cancer 1990; 65: 107-101.
29. Anders KH, Latta H, Chang BS, Tomiyasu U, Quddusi AS, Vinters HV. Lymphomatoid granulomatosis and malignant lymphoma of the central nervous system in the acquired immunodeficiency syndrome. Hum Pathol 1989; 20: 326-334.
30. Lin-Greenberg A, Villacin A. Moussa G. Lymphomatoid granulomatosis presenting as ulcerative gastrointestinal tract lesions in patients with human immunodeficiency virus infection. Arch Intern Med 1990; 150: 2581-2583.
31. Mittal K, Neri A, Feiner H, Schinella R, Alfonso F. Lymphomatoid granulomatosis in the acquired immunodeficiency syndrome. Evidence of Epstein-Barr virus infection and B-cell clonal selection without myc rearrangement. Cancer 1990; 65: 1345-1349.
32. Fauci AS, Haynes BF, Costa J, Katz P, Wolff SM. Lymphomatoid granulomatosis. Prospective clinical and therapeutic experience over 10 years. N Engl J Med 1982; 306: 68-74.
33. Israel HL, Patchefsky AS, Saldana MJ. Wegener's granulomatosis, lymphomatoid granulomatosis, and benign lymphocytic angiitis and granulomatosis of lung. Recognition and treatment. Ann Intern Med 1977; 87: 691-699.
34. Katzenstein AL Carrington CB, Liebow AA. Lymphomatoid granulomatosis. A clinicopathologic study of 152 cases. Cancer 1979; 43: 360-373.